Vimentin Positive Primary Thyroid Diffuse Large B-Cell Lymphoma: cytological diagnosis of two cases

Authors

  • Swati Bhardwaj Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029
  • Charanjeet Ahluwalia Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029
  • Ashish Kumar Mandal Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029

Keywords:

Thyroid, Cytology, FNAC, lymphoma, Diffuse large B cell lymphoma, immunocytochemistry

Abstract

Primary thyroid lymphomas are rare tumours of thyroid accounting for 5% of all thyroid tumours. Diffuse large B cell lymphoma is one of the most common type of primary thyroid lymphoma. Here we are presenting two rare cases of primary thyroid lymphoma. The first case is of a sixty year old female who presented with a rapidly enlarging thyroid mass, causing compressive symptoms. Radiological investigations revealed deviation and compression of trachea by the mass. Fine needle aspiration was performed, and routine as well as liquid based cytology smears were prepared. Smears revealed features of diffuse large B cell lymphoma of thyroid. Immunocytochemistry was performed that confirmed the diagnosis, and also revealed vimentin positive nature of the neoplasm, that has been shown to confer some degree of resistance to chemotherapy. A tru cut biopsy was performed that reconfirmed the diagnosis, and also helped in determining Ki67 proliferation index of the tumour that determines the aggressive nature of non-Hodgkin’s lymphomas. The second case is of a seventy year old woman who presented with a rapid enlargement of thyroid over a period of three months, leading to difficulty in breathing and dysphagia. Fine needle aspiration was performed that showed features of immunoblastic type of DLBCL. The diagnosis was confirmed by immunocytochemistry, which also showed vimentin positivity.  These two cases are important for their rarity, especially being vimentin positive, diagnosed on cytology with the aid of immunocytochemistry.

 

DOI: 10.21276/APALM.1137

Author Biographies

Swati Bhardwaj, Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029

Post graduate student, Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029

Charanjeet Ahluwalia, Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029

Professor, Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029

Ashish Kumar Mandal, Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029

Head of Department, Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi-110029

References

1. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. SeminOncol. 1999;26:316-323.
2. Green LD, Mack L, Pasieka JL. Anaplastic thyroid cancer and primary thyroid lymphoma: A review of these rare thyroid malignancies. J Surg Oncol.2006;94:725-736.
3. Graff-Baker A, Roman SA, Thomas DC, et al. Prognosis of primary thyroid lymphoma: Demographic, clinical, and pathological predictors of survival in 1,408 cases. Surgery. 2009;146:1105-1115.
4. Pederson RK, Pederson NT. Primary non-Hodgkin’s lymphoma of the thyroid gland: A population based study. Histopathology.1996;28:25-32.
5. Foppiani L, Secondo V, Arlandini A, Quilici P, Cabria M, Del Monte P. Thyroid lymphoma: a rare tumor requiring combined management.Hormones (Athens). 2009; 214-8.
6. Gupta N, Nijhawan R, Srinivasan R, Rajwanshi A, Dutta P, Bhansaliy A, Sharma SC. Fine needle aspiration cytology of primary thyroid lymphoma: a report of ten cases. Cytojournal. 2005;20:21.
7. Sasai K, Yamabe H, Haga H, et al. Non-Hodgkin’s lymphoma of the thyroid. A clinical study of twenty two cases. Acta Oncol.1996;35:457-462.
8. Li J, Hu R, Liao AJ, Shi HY, Yan W, Liu ZG. Ki67 proliferative index in non-Hodgkin’s lymphoma and its clinical significance. Zhongguo Shi Yan Xue Ye XueZaZhi. 2011;19(4):935-9.
9. Maxwell SA, Cherry EM, Bayless KJ. Akt, 14-3-3 , and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma. Leuk Lymphoma. 2011 May;52(5):849-64.

Downloads

Additional Files

Published

29-05-2017

How to Cite

1.
Bhardwaj S, Ahluwalia C, Mandal AK. Vimentin Positive Primary Thyroid Diffuse Large B-Cell Lymphoma: cytological diagnosis of two cases. Ann of Pathol and Lab Med [Internet]. 2017 May 29 [cited 2024 Dec. 26];4(3):C78-82. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/apalm1137

Issue

Section

Case Report